We describe a rapid and direct 125l-based radioimmunoassay for quantification of unconjugated (free) estriol in pregnancy serum. Estriol in serum is adsorbed onto a small column of Sephadex, thereby allowing its separation from proteins and interfering materials. A radioiodinated derivative of estriol (6-ketoestriol-6(o.carboxymethyl)oxime-[ '5l]tyrosine methyl ester) is added to the column, followed by a limiting amount of antiserum. After incubation, the antibody-bound hormone is separated by a buffer wash. The assay exhibits satisfactory recovery and parallelism, and the intra-and inter-assay coefficients of variation are <10%. The values obtained by using the assay correlate well (r = 0.97) with those from a comparison method in which solvent extraction and chromatographic purification are used.
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AddItional Keyphrases:
1251-based procedure #{149} Sephadex #{149} monitoring fetal status #{149} hormones According to experimental and clinical evidence, the feto-placental unit is responsible for the synthesis of estriol. In uncomplicated pregnancies, the production of estriol increases steadily throughout the last trimester; in pregnancies complicated by "placental insufficiency," the synthesis of estriol decreases rapidly (1) .
The most commonly used method for monitoring estriol synthesis (as an index to assess fetal stress) has been to measure estriol and estriol conjugates in a 24-h urine specimen. However, changes in renal clearance (2, 3) can make the results of those determinations suspect. Additionally, the sampling and handling of urine specimens and the 24-h delay in feto-placental assessment point to other serious disadvantages of this method. In recent years, investigators have evaluated the usefulness of measuring unconjugated estriol in pregnancy plasma as an alternative to the urinary assay. Sample collection is simplified and any deterioration in fetal status is more rapidly reflected in serial plasma specimens than in 24-h urines (4). In addition, unconjugated estriol in plasma is not affected by diurnal fluctuations or by the renal or positional changes that affect urinary estriol values (5, 6).
The reported (7-11) assays for unconjugated estriol in plasma are rather cumbersome and time-consuming.
In all, solvent extraction is used, and most require chromatographic separation of estriol before assay.
Recently this laboratory reported a novel approach to the separation and assay of free estriol (12). Here a column containing Sephadex is used to adsorb and separate estriol from plasma proteins and interfering materials. A radioimmunoassay in which tritiated estriol is used is then conducted in the column to quantify the hormone. Although this approach was shown to simplify the plasma estriol assay, the use of a tritium-labeled radioligand limits this assay to only those laboratories possessing liquid scintillation equipment.
To expand the application of the method, we modified the assay to allow use of a radio-iodinated derivative of estriol, 6-ketoestriol-6(o-carboxymethyl)oxime-[125I]tyrosine methyl ester (1251-TME-estriol).
The new assay is acceptably sensitive, precise, and accurate for measuring unconjugated estriol in plasma of women in the third trimester of pregnancy. cator, No. 6060) and Baker-Flex Silica Gel Plates lB-F.
Materials and Methods

Materials
The following solvent systems were used: ethyl acetate/isooctane, 5/20, 10/15, and 15/10 by vol. 
Assay Procedure
The Sephadex G-10 columns and stock standards were prepared as previously described (12). One milliliter of standard or sample diluted 11-fold was added to a column containing 1 ml of Sephadex G-10 (Pharmacia Labs, Inc., Piscataway, N. J. 08854) that had been pre-equilibrated with buffer, and the column was allowed to drain, washed with 8 ml of distilled water, and 1.0 ml of buffer added, followed by the radioligand.
The column was washed with 4 ml of buffer and then the outlet of the column was capped. One milliliter of buffer was added and the Sephadex gel bed was thoroughly mixed by use of a vortex-type mixer; the column outlet was uncapped and allowed to drain (all effluents to this point were discarded). The column was counted (total-counts value) and was placed over a plastic test tube for the addition of 500 zl of antiserum (that had been diluted to yield 40% binding of label in the absence of unlabeled estriol). After a 90-mm incubation at room temperature, 2.0 ml of buffer was added to the column to separate antibody-bound estriol from free estriol. The effluent was collected and counted to obtain a value for antiserum-bound estriol. For 10 clinical specimens, the entire procedure, including counting, can be completed within 3 h.
Results were calculated in terms of fraction bound (FB) or logit FB, by the following formulas: FB = Standard curves were obtained by plotting the logit values for standards vs. the log concentration of standards (in ng/ml, or zg/liter).
The values for the clinical samples were obtained from the logit standard curves and corrected for dilution.
Results and Discussion
During the preliminary phase of this study, we tried to simply replace the tritiated estriol radioligand with the radioiodinated derivative of estriol. However, as shown in Figure 1 , the dose/response curve developed with this iodinated radioligand was less sensitive than the dose/response curve developed with the tritiated radioligand. However, when sodium chloride was removed from the buffer used in the assay, the dose/response curve became almost superimposable upon the dose/response curve generated with the tritiated estriol radioligand (Figure 1 ). The effect was interpreted to be the net result of both a weakening in the attractive forces of Sephadex G-10 for the radioiodinated estriol derivative and a concomitant increase in the binding of antibody with radioligand.
Such an interpretation is supported by the observations and predictions of Eaker and Porath (14) concerning the increased adsorption of aromatic residues, such as the tyrosine moiety of the estriol derivative, to Sephadex G-10 in the presence of NaCl. further revision of the original Sephadex protocol. Whereas a water wash subsequent to the simultaneous addition of tracer and sample effectively removed cross-reacting water-soluble steroids from the sample in the tritium-based assay (12), it also effectively eluted the radioiodinated estriol derivative (Figure 2) . Consequently, the assay protocol was revised to include a delayed addition of the radioligand, and the gel bed was mixed before the antiserum was added, to distribute the specimen and radioligand uniformly throughout the column for subsequent interaction with the antiserum. With this procedure, estriol standards in plasma were shown to react like those prepared in buffer (Figure 3 ).
Comparison of Sephadex Estriol Methods
To establish that the modifications made in the scheme produced an assaycomparable to the tritium-based system, we compared results of these two assays by evaluating the estriol concentrations in clinical specimens. As shown in Figure 4 , the procedure utilizing the iodinated radioligand gave values for 34 clinical specimens close (r = 0.91) to those obtained with the tritiated Sephadex-column procedure. Although we did not use the same volume of water to eliminate cross-reactants in each of these studies, the mod- ifications we made in order to use the iodinated estriol radioligand had evidently not adversely affected the adsorption of endogenous estriol to the Sephadex. The new radioimmunoassay was therefore evaluated for its sensitivity, specificity, and accuracy.
Sensitivity.
The sensitivity of this assay is defined as the smallest concentration of estriol that gives a response significantly different from the response given by a specimen containing no estriol. At the 95% confidence limit the sensitivity of this assay is about 20 ng/liter; thus, the lowest detectable concentration in a specimen diluted 11-fold is about 220 ng/liter, a sensitivity adequate for monitoring unconjugated estriol in the serum of women in the third trimester of pregnancy (15) .
Precision. Figure 5 shows a mean standard curve (±2 SD) derived from 10 curves run on separate days. The intra-and inter-assay coefficients of variation over the range 0.50-4.04 gfliter are less than 10% (Table 1) . 
Specificity.
The specificity of the '251-column RIA for serum estriol was evaluated by determining how much cross reactivity with endogenous steroids similar in structure to estriol there was in the assay. The specificity of this assay depends on the use of both a relatively specific antiserum and a water-wash step to remove possible interfering compounds such as water-soluble conjugated derivatives of estriol from the reaction column. Table 2 shows the cross reactivity found with various steroids when a water wash of only 2.0 ml was used. Only estetrol and estriol-3-sulfate reacted to any extent, and only the latter could cause a substantial apparent increase in the estriol concentration of a serum from a term pregnancy. Because increased volumes of water have little effect upon the retention of estriol to Sephadex, a larger volume of water (8.0 ml) was used to ensure removal of cross-reactants for actual test specimens. To further test the specificity of the assay, we did a parallelism study. Samples were diluted to various extents and assayed, to determine if they would yield the same result when multiplied by the dilution factor. (An assay that gives parallel results suggests that various components of serum, including binding proteins and potentially cross-reactive steroids, do not interfere in the test.) As shown in Table 3,  acceptable results were obtained over a five-to 44-fold dilution range.
Accuracy. The accuracy of the assay was evaluated by determining the analytical recovery of exogenous estriol added to clinical specimens. Specimens were assayed before and after exogenous estriol was added in various amounts, and the amount of steroid analytically accounted for was calculated. The specimens included two pooled plasma samples from term pregnancies as well as individual plasma and serum specimens from diabetic and toxemic patients in the last trimester of pregnancy. The results (Table 4) indicate acceptable recovery.
The accuracy of the assay was also tested by a comparative analysis of 22 clinical specimens. The samples were assayed by the 1251..procedure and also by a method in which solvent extraction and chromatographic purification are used before assay (11) . Figure 6 gives a comparison of the results from the two assays. The correspondence between the two sets of data is very satisfactory, the correlation coefficient being 0.97 and the standard error of estimate being 
